T

Tarsons Products
TARSONS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₹12.41B
EV
₹16.06B
Shares Outstanding
53.21M
Beta
0.14
Industry
Medical - Instruments & Supplies

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
1
P/E 2026E
37.09x
P/Revenue 2026E
2.97x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2026E
67.50%
Net Profit Margin 2026E
8.02%
ROE 2026E
9.00%
ROCE 2025
4.79%

Dividends

DPS 2026E
-
Payout Ratio 2026E
-
Div. Yield 2026E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Tarsons Products Limited

gainify

T

Tarsons Products Limited

TARSONS

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Sehgal, Sanjive

Employees

906

IPO Date

2021-11-26

Headquarters

Martin Burn Business Park, Room No. 902, BP-3, Saltlake, Sector-V, Kolkata, West Bengal, 700091, India

📊 Stock Price & Performance

The last closing price of Tarsons Products (TARSONS) is ₹235.00, reflecting a +0.73% change from the prior session. Last updated: January 1, 2026 at 5:02 AM Eastern Time

Review the recent TARSONS stock performance trends:Past 1 Month: Tarsons Products (TARSONS) shares have +3.59%.Past 3 Months: The stock has -23.46%.Past 6 Months: TARSONS shares have -40.98%. Last updated: December 31, 2025 at 11:52 PM Eastern Time

Over the last year, Tarsons Products (TARSONS) has established a 52-week price range between a high of ₹458.00 and a low of ₹198.00. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:52 PM Eastern Time

Tarsons Products (TARSONS) is considered a low volatility stock. It has a beta of 0.14, which means it typically moves 0.14 times as much as the broader market. Over the past 52 weeks, TARSONS has traded within a ₹198.00 – ₹458.00 range. Last updated: December 31, 2025 at 11:52 PM Eastern Time

Based on current TARSONS analyst forecasts and market assumptions, the consensus price target for Tarsons Products (TARSONS) is ₹690.00 for 2027. Relative to the current price of ₹235.00, this implies a positive upside of +195.44%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: January 1, 2026 at 5:02 AM Eastern Time

💰 Financial Metrics & Reports

The current Tarsons Products (TARSONS) market capitalization is approximately ₹12.41B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Tarsons Products's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:52 PM Eastern Time

In the most recently reported quarter, Tarsons Products (TARSONS) generated ₹1.02B in revenue, representing a +3.10% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:56 AM Eastern Time

In the most recently reported fiscal year, Tarsons Products (TARSONS) generated net income of ₹297.70M, compared with ₹426.40M in the prior fiscal year, representing a -30.18% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of ₹346.00M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:56 AM Eastern Time

According to its latest quarterly filing, Tarsons Products (TARSONS) reported EBITDA of ₹274.43M, representing a +8.44% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 2:56 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.63x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 2:56 AM Eastern Time

Based on the latest available data, Tarsons Products (TARSONS) is currently trading at a last twelve months (LTM) P/E ratio of 60.72x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 5:02 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Tarsons Products (TARSONS) revenue was ₹1.02B, compared with analyst consensus expectations of ₹1.07B, representing a -4.28% revenue surprise versus expectations. Earnings per share (EPS) for the quarter were ₹0.62, compared with consensus estimates of ₹0.85, resulting in an -27.06% EPS surprise. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:56 AM Eastern Time

Tarsons Products (TARSONS) does not currently pay a dividend. Over the last twelve months (LTM), the company paid ₹0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:56 AM Eastern Time

📈 Analyst Information

Analyst assessments of whether Tarsons Products (TARSONS) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: ₹235.00Consensus price target: ₹690.00Implied return: +195.44% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 5:02 AM Eastern Time

Based on the latest available analyst coverage, Tarsons Products (TARSONS) currently carries a Buy consensus rating. Analysts' average TARSONS price target is ₹690.00. Relative to the current share price of ₹235.00, this suggests a potential price change of approximately +195.44%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 5:02 AM Eastern Time

Like other publicly traded stocks, Tarsons Products (TARSONS) shares are bought and sold on stock exchanges such as NSEI and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Tarsons Products (TARSONS) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add TARSONS to your watchlist.

Tarsons Products trades under the ticker symbol TARSONS on the NSEI stock exchange. The ticker TARSONS is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Tarsons Products (TARSONS) employs approximately 906 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:52 PM Eastern Time

Tarsons Products (TARSONS) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Tarsons Products (TARSONS) stock peers based on overlapping products, services, and competitive dynamics:Guangzhou Jet Bio-Filtration (688026)Gerresheimer (GXI)Waters (WAT)Mettler-Toledo International (MTD)Agilent Technologies (A)Thermo Fisher Scientific (TMO)Becton (BDX)Corning (GLW) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Tarsons Products.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.